The Peptide Wiki
Mapping Knowledge.
Advancing Discovery.
📩 Subscribe
// LICENSED · CLINICIAN-GUIDED

Licensed Pharmacies & Telehealth

Affiliate disclosure: Some links on this page are affiliate or referral links. If you start a consultation or purchase through them, we may earn a referral fee at no additional cost to you. Our listings are editorial and are not influenced by commission. See our full affiliate disclosure.
These are licensed telehealth providers and the pharmacies that fill their prescriptions. Unlike research-chemical suppliers, a licensed clinician evaluates you first, the medication is dispensed by a licensed pharmacy (branded FDA-approved or pharmacy-compounded), and you receive a clinician-guided protocol rather than an unlabeled research vial. We list these because many readers researching compounds want a supervised, prescription pathway. We are a publisher, not a provider. We do not prescribe, dispense, or compound anything, and nothing here is medical advice. Availability and legality vary by state and are changing; see each listing and its regulatory note.

This is a separate category from our research vendor directory. Providers are listed branded FDA-approved first, then by legitimacy signals. We do not rank by commission.

Licensed · Clinician-Guided Branded FDA-approved

Hims & Hers

  • Access: Requires a medical consultation with a licensed clinician.
  • Dispensing: Branded FDA-approved (Novo Nordisk).
  • States served: Nationwide.
  • What is included: Provider evaluation, branded FDA-approved medication dispensed by a licensed pharmacy, ongoing clinician check-ins.
  • Listed for: Semaglutide.
  • Legitimacy signals: Publicly traded telehealth company (NYSE: HIMS); licensed clinician network; dispenses branded FDA-approved GLP-1 medication; nationwide coverage.
Start a consultation → Referral partnership pending. This link points to the provider's own site with no tracking parameters.
Licensed · Clinician-Guided Branded FDA-approved

Ro

  • Access: Requires a medical consultation with a licensed clinician.
  • Dispensing: Branded FDA-approved manufacturer.
  • States served: Nationwide.
  • What is included: Provider evaluation, branded FDA-approved medication dispensed by a licensed pharmacy, ongoing clinician support.
  • Listed for: Semaglutide, Tirzepatide.
  • Legitimacy signals: National telehealth platform; licensed clinician network; dispenses branded FDA-approved GLP-1 medication.
Start a consultation → Referral partnership pending. This link points to the provider's own site with no tracking parameters.
Licensed · Clinician-Guided Branded or pharmacy-compounded

Eden

  • Access: Requires a medical consultation with a licensed clinician.
  • Dispensing: Licensed pharmacy.
  • States served: 50 states.
  • What is included: Provider evaluation, GLP-1 medication via a licensed pharmacy, home delivery.
  • Listed for: Semaglutide, Tirzepatide.
  • Legitimacy signals: Licensed clinician network; GLP-1 telehealth with home delivery; 50-state coverage.
Regulatory note: compounded-peptide status is under FDA review. The Pharmacy Compounding Advisory Committee reviews several peptides on July 23 to 24, 2026, and the FDA has proposed changes to the 503B bulk-substances list for compounded GLP-1 medications. Availability and legality may change.
Start a consultation → Referral partnership pending. This link points to the provider's own site with no tracking parameters.
Licensed · Clinician-Guided Branded or pharmacy-compounded

Invigor Medical

  • Access: Requires a medical consultation with a licensed clinician.
  • Dispensing: Licensed pharmacy.
  • What is included: Provider evaluation, prescription peptide and GLP-1 options dispensed by a licensed pharmacy.
  • Listed for: BPC-157, Semaglutide, Sermorelin, Tirzepatide.
  • Legitimacy signals: Licensed telehealth clinic; peptide and GLP-1 focused; provider evaluation required.
Regulatory note: compounded-peptide status is under FDA review. The Pharmacy Compounding Advisory Committee reviews several peptides on July 23 to 24, 2026, and the FDA has proposed changes to the 503B bulk-substances list for compounded GLP-1 medications. Availability and legality may change.
Start a consultation → Referral partnership pending. This link points to the provider's own site with no tracking parameters.
Licensed · Clinician-Guided Branded or pharmacy-compounded

Mochi Health

  • Access: Requires a medical consultation with a licensed clinician.
  • Dispensing: Licensed pharmacy (branded or compounded).
  • What is included: Provider evaluation, GLP-1 medication via a licensed pharmacy, hormone and menopause care.
  • Listed for: Semaglutide, Tirzepatide.
  • Legitimacy signals: Licensed clinician network; partners with health and wellness publishers; GLP-1 and hormone care.
Regulatory note: compounded-peptide status is under FDA review. The Pharmacy Compounding Advisory Committee reviews several peptides on July 23 to 24, 2026, and the FDA has proposed changes to the 503B bulk-substances list for compounded GLP-1 medications. Availability and legality may change.
Start a consultation → Referral partnership pending. This link points to the provider's own site with no tracking parameters.
Licensed · Clinician-Guided Branded or pharmacy-compounded

Yucca Health

  • Access: Requires a medical consultation with a licensed clinician.
  • Dispensing: Licensed compounding pharmacy (branded when available).
  • States served: 50 states.
  • What is included: Provider evaluation, GLP-1 medication via a licensed pharmacy, UPS 2-day home delivery.
  • Listed for: Semaglutide, Tirzepatide.
  • Legitimacy signals: Licensed clinician network; compounded and branded GLP-1 options; UPS 2-day fulfillment; 50-state coverage.
Regulatory note: compounded-peptide status is under FDA review. The Pharmacy Compounding Advisory Committee reviews several peptides on July 23 to 24, 2026, and the FDA has proposed changes to the 503B bulk-substances list for compounded GLP-1 medications. Availability and legality may change.
Start a consultation → Referral partnership pending. This link points to the provider's own site with no tracking parameters.
Licensed · Clinician-Guided Prescription peptide

TeleWellnessMD

  • Access: Requires a medical consultation with a licensed clinician.
  • Dispensing: Licensed compounding pharmacy.
  • What is included: Provider evaluation, prescription peptide and wellness options dispensed by a licensed pharmacy.
  • Listed for: BPC-157, CJC-1295, Ipamorelin, Semaglutide, Sermorelin, Tirzepatide.
  • Legitimacy signals: Licensed telehealth clinic; peptide and wellness focus; provider evaluation required.
Regulatory note: compounded-peptide status is under FDA review. The Pharmacy Compounding Advisory Committee reviews several peptides on July 23 to 24, 2026, and the FDA has proposed changes to the 503B bulk-substances list for compounded GLP-1 medications. Availability and legality may change.
Start a consultation → Referral partnership pending. This link points to the provider's own site with no tracking parameters.

Educational information only, not medical advice, diagnosis, or treatment guidance. The Peptide Wiki is a publisher, not a clinic or a pharmacy. Consult a qualified licensed clinician before any medical decision. Availability, pricing, and legality vary by state and change over time.